Bioweapon

Bioweapon Order Description For this assignment, Part One of your course project, assume the role of Dr. Madness. Your rogue nation seeks global domin" rel="nofollow">ination. With a bare bones laboratory and your exhaustive microbiological and epidemiological knowledge, you (Dr. Madness) decide that the best way to rule the world is to create and dissemin" rel="nofollow">inate the perfect biological weapon. For this part of the assignment, you will develop your weapon from the ground up. Discuss nearly all of the epidemiological criteria related to it, and justify and discuss why it is used and how effective it is. This agent could be a hybrid of other biological pathogens or an entirely new one. If the agent is newly created, there must be some basis and epidemiological support of a similar agent by which you can base your justification. In other words, it will be unrealistic to create an airborne virus that in" rel="nofollow">inoculates and kills within" rel="nofollow">in one hour. There must be a realistic exposure and in" rel="nofollow">incubation time and must be supported through current agent biology or biochemistry (for example, in" rel="nofollow">influenza exposure and in" rel="nofollow">incubation takes 1–4 days). • Name of Agent: Explain" rel="nofollow">in why you chose the name. If it is a biological agent, be sure to provide a taxonomic name • Etiology: This will talk about the genesis of your agent. Where was it discovered? How was it made? How long has it been around? Why was this agent created? What were the social and economic factors of your rogue nation that made Dr. Madness focus on this element of the agent? What are the environmental precursors to this agent? Discuss the in" rel="nofollow">interaction among agent, host, and environment. • Identification: This will describe the basics of the agent. Is it a bacteria, virus, toxin" rel="nofollow">in, parasite, hybrid, or somethin" rel="nofollow">ing else? Discuss how your agent presents within" rel="nofollow">in the human population. What are the symptoms in" rel="nofollow">in humans? What are the (zoonotic) symptoms in" rel="nofollow">in animals? How does the disease progress? Are there stages? Discuss the various stages in" rel="nofollow">includin" rel="nofollow">ing length of in" rel="nofollow">infection, severity, and the like. What are the diagnostic in" rel="nofollow">indicators? How would a doctor be able to identify this agent in" rel="nofollow">in a clin" rel="nofollow">inic or emergency room? • Laboratory Analysis: How will the agent be identified? Can it be grown in" rel="nofollow">in media? What type of laboratory methods can be used to identify the agent (microscopy, chromatography, PCR, and so on)? • Occurrence: This is the epi: who, what, when, where, how, and why of the disease. Where does it happen? When can it be found? Who is most and least susceptible to the agent (risk factors). More exotic and hard to fin" rel="nofollow">ind agents are harder to prevent and control but are also more difficult to in" rel="nofollow">initiate an epidemic or pandemic, whereas more generalized and known agents may be easier to cure, but have a much wider swath of causin" rel="nofollow">ing pandemics. How do socioeconomic factors foster or in" rel="nofollow">inhibit the spread of disease? • Reservoir: What is the natural reservoir of the agent? Are there other organisms where this agent can reside without causin" rel="nofollow">ing disease? Increasin" rel="nofollow">ing the reservoir can enhance transmission but can also allow for easier identification and treatment in" rel="nofollow">in response to it. • Mode of Transmission: Consider in" rel="nofollow">inhalation, absorption, digestion, contact, and so forth. If you use multiple modes, justify your selections. • Incubation Period: Provide the range with an average (median) day of disease onset. Does the period change in" rel="nofollow">in different socioeconomic status identifiers (sex, age, race, creed, and so on)? Why or why not? • Period of communicability: How long is a person with this agent contagious? Increasin" rel="nofollow">ing this period also in" rel="nofollow">increases the opportunity for study and thus treatment and control. • Susceptibility: Is the agent susceptible to rein" rel="nofollow">infection of the same person? Allowin" rel="nofollow">ing for this in" rel="nofollow">increases morbidity but usually mortality wanes in" rel="nofollow">in subsequent in" rel="nofollow">infections. Takin" rel="nofollow">ing on the role of Dr. Madness, generate your superweapon and describe the weapon usin" rel="nofollow">ing the above mentioned criteria. Remember, the focus in" rel="nofollow">in on creatin" rel="nofollow">ing somethin" rel="nofollow">ing that becomes difficult to identify, monitor, or treat with prophylaxis. You will write out the proposal as Dr. Madness submittin" rel="nofollow">ing this to his lead researcher to develop. This proposal should be approximately 6–8 pages in" rel="nofollow">in length, but some submissions may be longer. Project Requirements To achieve a successful project experience and outcome, you are expected to meet the followin" rel="nofollow">ing requirements. • Written communication: Written communication is free of errors that detract from the overall message. • APA formattin" rel="nofollow">ing: Resources and citations should be formatted accordin" rel="nofollow">ing to current APA style and formattin" rel="nofollow">ing. • Resources: Include all literature cited in" rel="nofollow">in the project. • Length of paper: 6–8 typed, sin" rel="nofollow">ingle-spaced pages, not in" rel="nofollow">includin" rel="nofollow">ing cover page and resource list. • Font and font size: Arial, 10 poin" rel="nofollow">int.